Announcements Trials
Browse Landscape

Phase

Phase 2 75Phase 1 41Phase 3 32Phase 1/2 21Phase 4 5Phase NA 4Phase EARLY_PHASE1 3Phase 2/3 2

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gastrointestinal 2CNS 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 3Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm, Residual 1

Interventions

Letrozole 9Fluorodeoxyglucose F18 7pembrolizumab 6Magnetic Resonance Spectroscopy 6atezolizumab 5Blood Specimen Collection 5Trastuzumab 4Oncolytic Virotherapy 4Biopsy 4Bevacizumab 4palbociclib 3durvalumab 3Vitamin D 3Taxes 3Saline Solution 3Radiotherapy 3Metformin 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Albumin-Bound Paclitaxel 3pertuzumab 2olaparib 2bazedoxifene 2Vinorelbine 2Tamoxifen 2Sentinel Lymph Node Biopsy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × palbociclib × Breast × Clear all
NCT02913430 2024-09-23

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

University of Pittsburgh

Phase EARLY_PHASE1 Completed
7 enrolled 13 charts
Breast

Breast Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT04130152 2022-10-25

PROMETEO II

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed
22 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡